ALEXANDRIA GLENDENNING: Open Payments
NPI 1629619937 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 78 payments from 15 companies in 2025. Trend: 2023 $1,416 · 2024 $1,070 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $199 |
| Novo Nordisk Inc | 12 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $173 |
| Lilly USA, LLC | 7 | $120 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| PFIZER INC. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Gilead Sciences, Inc. | 2 | $52 |
| Corcept Therapeutics | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: CAPLYTA, MOUNJARO, Wegovy, VRAYLAR, Ozempic, Auvelity, Kerendia, QULIPTA.
Industry payments across OK — which companies pay providers there.
